论文部分内容阅读
虽然现已公认溶栓疗法可提高急性心肌梗塞后的存活率,但溶栓后梗塞区供血冠脉再通的速度是否影响其预后尚有争论。为探讨这一问题,作者进行了以下研究。 方法 2431例病人随机分组,接受以下四种方法之一的再灌注治疗:①链激酶(SK)150万U60分钟内静滴+肝素纳12500U皮下注射;每日两次(SK第Ⅰ组);②SK150万U静滴+肝素5000U静注后以每小时1000U连
Although thrombolytic therapy is now known to improve survival after acute myocardial infarction, it remains controversial whether the rate of coronary recanalization of blood supply to the infarct area after thrombolysis affects its prognosis. To explore this issue, the author conducted the following research. Methods A total of 2431 patients were randomly divided into four groups: ① streptokinase (SK) 1.5 million U intravenously within 60 minutes and heparin 12500U subcutaneously twice a day (SK group Ⅰ); ② SK15 million U intravenous infusion of heparin 5000U intravenous infusion 1000U per hour